Intelligent Bio Solutions Inc. (NasdaqCM: INBS)
Health Care · Health Care Equipment & Supplies · US
$1.53
-7.83% today · -85.7% 1Y
Intelligent Bio Solutions Inc. (NasdaqCM: INBS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $4.63M and employs 59 people.
Over the last twelve months the share price has lost 85.7%, trading between 1.52 and 24.90.
Tweenvest scores Intelligent Bio Solutions Inc. across four factors: quality 36/100, value 55/100. Its strongest factor is value.
INBS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.63M
- Revenue (TTM)
- $4.22M
- P/E
- —
- EPS
- -8.44
- Dividend yield
- —
- Beta (5Y)
- 4.30
- 52-week high
- $24.90
- 52-week low
- $1.52
- Avg volume (3M)
- —
- Shares outstanding
- 3.03M
- Employees
- 59
- Next earnings
- —
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
- ISIN
- US36151G7097
- Founded
- 2016
- Listed since
- Dec 23, 2020
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Surgical Innovations Group plcAIM: SUN | $4.94M | £0.00 | -5.88% |
| Cambridge Nutritional Sciences plcAIM: CNSL | $4.88M | £0.02 | +10.71% |
| StimCell Energetics Inc.OTCPK: STME | $4.80M | $0.23 | — |
| 20/20 Biolabs, Inc.NasdaqCM: AIDX | $4.79M | $0.38 | -1.32% |
| KMS Medisurgi LimitedBSE: 540468 | $4.58M | Rs— | — |
| Aethlon Medical, Inc.NasdaqCM: AEMD | $4.30M | $6.05 | -6.20% |
| ScandiDos AB (publ)OM: SDOS | $4.28M | Skr0.60 | -0.83% |
| Qlife Holding AB (publ)OM: QLIFE | $4.05M | Skr1.40 | -12.38% |
Figures last refreshed Oct 11, 2026.